Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Bremelanotide (Vyleesi) vs Insulin Glargine (Lantus)
An educational, source-based comparison of Bremelanotide (Vyleesi) and Insulin Glargine (Lantus) — how each peptide works, what it's researched for, and what to know before going deeper.
Melanocortin receptor agonist for hypoactive sexual desire disorder in premenopausal women.
Cyclic 7-amino-acid synthetic analog of α-MSH that activates melanocortin receptors (primarily MC4R) in the CNS, modulating sexual desire pathways.
- Acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women
- • FDA-approved.
- • Nausea, flushing, transient BP elevation common.
Long-acting basal insulin analog for type 1 and type 2 diabetes.
Recombinant human insulin analog with two arginine residues added to the B-chain and asparagine→glycine at A21, forming microprecipitates at injection site for ~24-hour glucose-lowering activity via insulin receptor activation.
- Type 1 diabetes basal coverage
- Type 2 diabetes basal insulin therapy
- Gestational diabetes
- • FDA-approved.
- • Hypoglycemia and weight gain are primary risks.
- • Do not mix with other insulins.
Bremelanotide (Vyleesi) vs Insulin Glargine (Lantus) — Key differences
- Class: Bremelanotide (Vyleesi) is classified as Melanocortin Agonist · Sexual Health, while Insulin Glargine (Lantus) is Insulin Analog · Endocrine.
- Primary research focus: Bremelanotide (Vyleesi) — acquired, generalized hypoactive sexual desire disorder (hsdd) in premenopausal women; Insulin Glargine (Lantus) — type 1 diabetes basal coverage.
- Tag: FDA-Approved · Sexual Health vs FDA-Approved · Diabetes.